Clinical • P2 data • Combination therapy • Oncolytic virus • MSi-H Biomarker • PD(L)-1 Biomarker • IO biomarker • Metastases
|
MSI (Microsatellite instability) • CD40 (CD40 Molecule)
|
MSI-H/dMMR • CSF2 expression
|
Avastin (bevacizumab) • Tecentriq (atezolizumab) • RP2 • RP3